Ivacaftor modifies cystic fibrosis neutrophil phenotype in subjects with R117H residual function CFTR mutations

Παρόμοια τεκμήρια

• Ivacaftor decreases monocyte sensitivity to interferon-γ in people with cystic fibrosis
  ανά: Hisert, Katherine B., κ.ά.
  Έκδοση: (2020)
• Ivacaftor-induced sweat chloride reductions correlate with increases in airway surface liquid pH in cystic fibrosis
  ανά: Alaiwa, Mahmoud H. Abou, κ.ά.
  Έκδοση: (2018)
• Acute administration of ivacaftor to people with cystic fibrosis and a G551D-CFTR mutation reveals smooth muscle abnormalities
  ανά: Adam, Ryan J., κ.ά.
  Έκδοση: (2016)
• Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR
  ανά: Wainwright, C.E., κ.ά.
  Έκδοση: (2015)
• In Vivo and In Vitro Ivacaftor Response in Cystic Fibrosis Patients With Residual CFTR Function: N-of-1 Studies
  ανά: McGarry, Meghan E., κ.ά.
  Έκδοση: (2017)